Copyright
©The Author(s) 2025.
World J Clin Pediatr. Dec 9, 2025; 14(4): 108897
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.108897
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.108897
Figure 1 Characteristic features of Noonan syndrome.
A: Low-set ears with thick helices, short neck with excess nuchal skin, and low posterior hairline; B: Pectus excavatum; C: Broad forehead, hypertelorism, epicanthic folds, downward slanting palpebral fissures, prominent eyes, mild ptosis, micrognathia, and prominent nasolabial fold. The patient also had pulmonary stenosis on echocardiography and horse-shoe kidneys on ultrasound and combined pituitary hormone deficiency. Whole exome sequencing revealed a pathogenic mutation in the POU1F1 gene.
Figure 2 Changes in height standard deviation scores after 6 months and 1 year of recombinant growth hormone therapy in the three groups.
1Height SDS are calculated from normative data from Indian Academy of Pediatrics 2015 growth charts. GH: Growth hormone; CPHD: Combined pituitary hormone deficiency; SDS: Standard deviation scores; NS: Noonan syndrome.
- Citation: Basu R, Bera S, Mondal S, Shah S, Swapnil K, Nanda R, Datta J, Mandal S, Goswami S, Baidya A, Sengupta N. Deficiency of anterior pituitary hormones in Noonan syndrome and its impact on response to growth hormone therapy. World J Clin Pediatr 2025; 14(4): 108897
- URL: https://www.wjgnet.com/2219-2808/full/v14/i4/108897.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v14.i4.108897
